Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peptide Hormones | 6 | 2022 | 68 | 3.600 |
Why?
|
| Peptide Fragments | 6 | 2022 | 688 | 2.500 |
Why?
|
| Fibrillin-1 | 7 | 2026 | 59 | 1.690 |
Why?
|
| Microfilament Proteins | 4 | 2022 | 269 | 1.600 |
Why?
|
| Thirst | 1 | 2024 | 5 | 0.860 |
Why?
|
| Adipokines | 6 | 2026 | 118 | 0.780 |
Why?
|
| Purkinje Cells | 1 | 2024 | 165 | 0.750 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 1 | 2022 | 5 | 0.730 |
Why?
|
| Hormones | 1 | 2021 | 162 | 0.660 |
Why?
|
| Cerebellum | 1 | 2024 | 440 | 0.640 |
Why?
|
| Nuclear Receptor Coactivator 2 | 4 | 2013 | 148 | 0.620 |
Why?
|
| Appetite Regulation | 1 | 2017 | 40 | 0.520 |
Why?
|
| Metabolic Syndrome | 1 | 2021 | 365 | 0.520 |
Why?
|
| Glucose | 5 | 2022 | 851 | 0.500 |
Why?
|
| Energy Metabolism | 2 | 2020 | 802 | 0.500 |
Why?
|
| Fasting | 2 | 2016 | 304 | 0.490 |
Why?
|
| Hypothalamus | 1 | 2017 | 198 | 0.480 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 981 | 0.450 |
Why?
|
| Liver | 6 | 2016 | 1789 | 0.390 |
Why?
|
| Mice | 12 | 2024 | 18222 | 0.370 |
Why?
|
| Obesity | 2 | 2022 | 2384 | 0.360 |
Why?
|
| Mice, Inbred C57BL | 6 | 2024 | 4714 | 0.350 |
Why?
|
| Animals | 13 | 2024 | 33866 | 0.320 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2011 | 195 | 0.300 |
Why?
|
| Body Weight | 2 | 2026 | 986 | 0.300 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2011 | 169 | 0.300 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 1444 | 0.300 |
Why?
|
| Dietary Fats | 1 | 2011 | 275 | 0.300 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2008 | 17 | 0.290 |
Why?
|
| Glycogen Storage Disease Type I | 1 | 2008 | 10 | 0.290 |
Why?
|
| Mice, Transgenic | 3 | 2024 | 2333 | 0.250 |
Why?
|
| Blood Glucose | 2 | 2021 | 1109 | 0.240 |
Why?
|
| Mice, Knockout | 5 | 2024 | 3824 | 0.230 |
Why?
|
| Postmenopause | 1 | 2026 | 135 | 0.230 |
Why?
|
| Drinking | 1 | 2024 | 27 | 0.210 |
Why?
|
| Optogenetics | 1 | 2024 | 73 | 0.200 |
Why?
|
| Weight Gain | 1 | 2026 | 383 | 0.200 |
Why?
|
| Agouti-Related Protein | 1 | 2022 | 50 | 0.180 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2021 | 92 | 0.170 |
Why?
|
| Appetite | 1 | 2021 | 36 | 0.170 |
Why?
|
| Ligands | 1 | 2022 | 482 | 0.160 |
Why?
|
| HEK293 Cells | 1 | 2022 | 806 | 0.160 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 785 | 0.150 |
Why?
|
| Gene Expression Regulation | 4 | 2012 | 2333 | 0.150 |
Why?
|
| Male | 10 | 2024 | 64536 | 0.140 |
Why?
|
| Nerve Tissue Proteins | 1 | 2024 | 1082 | 0.140 |
Why?
|
| Hepatocytes | 2 | 2011 | 235 | 0.140 |
Why?
|
| Appetite Depressants | 1 | 2017 | 23 | 0.130 |
Why?
|
| Humans | 10 | 2026 | 130556 | 0.120 |
Why?
|
| Progeria | 1 | 2016 | 17 | 0.120 |
Why?
|
| Mice, Obese | 1 | 2016 | 74 | 0.120 |
Why?
|
| Adipose Tissue, White | 1 | 2016 | 97 | 0.110 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2016 | 158 | 0.110 |
Why?
|
| Cyclic AMP | 1 | 2016 | 227 | 0.110 |
Why?
|
| Antibodies | 1 | 2016 | 319 | 0.110 |
Why?
|
| Sequence Alignment | 1 | 2016 | 583 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2011 | 2896 | 0.100 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 2014 | 31 | 0.100 |
Why?
|
| Nuclear Receptor Coactivator 3 | 2 | 2013 | 258 | 0.100 |
Why?
|
| Nuclear Receptor Coactivator 1 | 2 | 2013 | 162 | 0.100 |
Why?
|
| Fetal Growth Retardation | 1 | 2016 | 254 | 0.100 |
Why?
|
| Molecular Sequence Data | 2 | 2016 | 3470 | 0.100 |
Why?
|
| Circadian Rhythm | 1 | 2016 | 317 | 0.100 |
Why?
|
| Hypoglycemia | 2 | 2012 | 184 | 0.090 |
Why?
|
| Recombinant Proteins | 1 | 2016 | 1317 | 0.090 |
Why?
|
| Urinary Bladder | 1 | 2014 | 219 | 0.090 |
Why?
|
| Carnitine Acyltransferases | 1 | 2012 | 5 | 0.090 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2013 | 64 | 0.090 |
Why?
|
| Amino Acid Sequence | 1 | 2016 | 2397 | 0.090 |
Why?
|
| Actins | 1 | 2014 | 315 | 0.090 |
Why?
|
| Heterozygote | 1 | 2014 | 725 | 0.090 |
Why?
|
| Rats | 1 | 2017 | 3383 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2017 | 4672 | 0.090 |
Why?
|
| Colon | 1 | 2014 | 363 | 0.080 |
Why?
|
| Muscular Diseases | 1 | 2012 | 124 | 0.080 |
Why?
|
| Insulin | 1 | 2016 | 1140 | 0.080 |
Why?
|
| Malabsorption Syndromes | 1 | 2011 | 27 | 0.080 |
Why?
|
| Hep G2 Cells | 1 | 2011 | 87 | 0.080 |
Why?
|
| Ablation Techniques | 1 | 2011 | 30 | 0.080 |
Why?
|
| Intestinal Absorption | 1 | 2011 | 170 | 0.080 |
Why?
|
| Gluconeogenesis | 1 | 2010 | 93 | 0.080 |
Why?
|
| Metabolome | 1 | 2013 | 325 | 0.080 |
Why?
|
| Cholic Acid | 1 | 2009 | 19 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2009 | 29 | 0.070 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 419 | 0.070 |
Why?
|
| Retinoic Acid Receptor alpha | 1 | 2008 | 18 | 0.070 |
Why?
|
| Liver Glycogen | 1 | 2008 | 22 | 0.070 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2008 | 77 | 0.070 |
Why?
|
| Bile Acids and Salts | 1 | 2011 | 260 | 0.070 |
Why?
|
| Response Elements | 1 | 2008 | 102 | 0.070 |
Why?
|
| Abnormalities, Multiple | 1 | 2014 | 964 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 242 | 0.070 |
Why?
|
| Neurons | 1 | 2017 | 2023 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 1211 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2011 | 1572 | 0.060 |
Why?
|
| RNA Interference | 1 | 2008 | 493 | 0.060 |
Why?
|
| Female | 5 | 2026 | 70427 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2011 | 538 | 0.060 |
Why?
|
| Gene Regulatory Networks | 1 | 2009 | 376 | 0.060 |
Why?
|
| Triglycerides | 1 | 2008 | 602 | 0.060 |
Why?
|
| Gene Expression Profiling | 2 | 2010 | 1806 | 0.060 |
Why?
|
| Women's Health | 1 | 2026 | 133 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 1367 | 0.050 |
Why?
|
| Young Adult | 1 | 2017 | 10015 | 0.050 |
Why?
|
| Body Composition | 1 | 2026 | 543 | 0.050 |
Why?
|
| Kidney | 1 | 2008 | 1279 | 0.040 |
Why?
|
| Adolescent | 2 | 2017 | 20774 | 0.040 |
Why?
|
| Mutation | 1 | 2014 | 6093 | 0.040 |
Why?
|
| Fatty Acids | 2 | 2013 | 373 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2026 | 1679 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2010 | 223 | 0.040 |
Why?
|
| Adult | 2 | 2017 | 31157 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2026 | 3355 | 0.040 |
Why?
|
| Muscle, Skeletal | 2 | 2013 | 1004 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2026 | 6438 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 2014 | 114 | 0.030 |
Why?
|
| Ketosis | 1 | 2012 | 14 | 0.020 |
Why?
|
| Plasma | 1 | 2013 | 103 | 0.020 |
Why?
|
| Hyperammonemia | 1 | 2012 | 59 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 434 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 190 | 0.020 |
Why?
|
| Amino Acids | 1 | 2013 | 561 | 0.020 |
Why?
|
| Exome | 1 | 2014 | 1063 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 372 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 1016 | 0.020 |
Why?
|
| Myocardium | 1 | 2013 | 859 | 0.020 |
Why?
|
| Aged | 1 | 2026 | 20900 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 1456 | 0.020 |
Why?
|
| Middle Aged | 1 | 2026 | 28416 | 0.010 |
Why?
|
| Base Sequence | 1 | 2009 | 2734 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2009 | 1694 | 0.010 |
Why?
|
| Genomics | 1 | 2009 | 1616 | 0.010 |
Why?
|
| Brain | 1 | 2013 | 3170 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2009 | 2420 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2014 | 14989 | 0.010 |
Why?
|
| Child | 1 | 2014 | 26175 | 0.010 |
Why?
|